Dr Jane Elliott AM, Dr Sonia Davison, Prof Rod Baber AM & Dr James Brown unpack the evidence, misconceptions and practical decision-making that shape real-world menopause and perimenopause care in Australian general practice.
Prof Rodney Baber AM breaks down the FDA’s MHT decision and provides a clear, evidence-based perspective on what matters for safe and balanced menopause care.
An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.
This lecture will clarify risk concepts in MHT, helping GPs understand and apply terms like absolute risk and hazard ratios in clinical decision-making.
In this Product Explainer, Gynaecologist Prof Rod Baber AM provides an update on the drospirenone 4mg progestogen-only oral contraceptive pill, including PBS information.
In this Product Explainer, Obstetrician and Gynaecologist Prof Rod Baber provides updates on doses options, PBS information and correct application of 0.1% w/w transdermal estradiol gel for the treatment of menopausal vasomotor symptoms.
In this episode, Dr Rod Baber, Obstetrician and Gynaecologist, answers questions about the new medication fezolinetant that were compiled by GPs and health professionals around Australia, alongside host Dr Terri Foran, GP and Medical Educator.
In this Product Explainer, Professor Rod Baber, a Clinical Professor of Obstetrics and Gynaecology at The University of Sydney discusses why estradiol gel should be used, how it is administered and when it should be prescribed and used (4 mins).
In this Product Explainer, Prof Rod Baber, a Clinical Professor of Obstetrics and Gynaecology at Sydney Medical School, University of Sydney and Head of the Menopause and Menstrual Disorders Clinic, Royal North Shore Hospital, explains when to use; how to use; and why to use progesterone for postmenopausal women. (6 mins)
In this Product Explainer, Prof Rod Baber, Gynaecologist and Head of the Menopause and Menstrual Disorders Clinic at the Royal North Shore Hospital explains the role of estradiol and dydrogesterone post menopausal hormone therapy for women during menopause transition, as well as why and when to use it (6 mins).
Menopausal hormone therapy is an effective way to control menopausal symptoms- key indications and contraindications for the use of MHT, the overall benefits and risks, how to prescribe MHT for a variety of women, long term follow up.
Chairman - Dr Rod Baber, GP and Medical Educator talks to Prof Susan Davis AO, Consultant Endocrinologist and Prof Janice Rymer, Professor of Obstetrics and Gynaecology
In this Product Explainer, Obstetrician and Gynaecologist Prof Rod Baber explains the role of fezolinetant for the treatment of vasomotor symptoms associated with menopause...
Save 50% on all seminars. Hurry, sale ends Dec 31!
You're invited to attend the Women's & Children's Health Update 2026, Australia's most popular seminar for GPs and healthcare professionals. Secure your seat by midnight Dec 31 and save!